Stéphane Bancel
$2.7B
as of 10/04/24
About Stéphane Bancel
Stephane Bancel is the CEO of Cambridge, Massachusetts-based biotech firm Moderna, known for its Covid-19 vaccine.
He became CEO of Moderna in 2011 and owns a roughly 8% stake in the publicly traded company.
Before joining Moderna, Bancel was the CEO of French diagnostics company BioM?rieux, founded by fellow French billionaire Alain M?rieux.
Moderna's Covid-19 vaccine was granted full FDA approval in January 2022; it had previously received emergency-use authorization in December 2020.
Moderna was founded in 2010 and went public in December 2018; the company develops drugs and vaccines using messenger RNA.
Personal stats
Citizenship
FranceSource of wealth
Biotech, vaccinesResidence
Boston, MassachusettsMarital status
MarriedBirth date
07/20/72 (age 52)Number of children
2Education
Master of Science in Engineering, Ecole Centrale Paris; Master of Business Administration, Harvard University; Master of Science in Engineering, University of MinnesotaSelf-made
self-madeStéphane Bancel’s fortune is worth
45K
troy ounces of gold
41K
median U.S. household
27K
median U.S. income
0.054%
U.S. credit card volume
0.011%
GDP of the United States
0.008%
United States debt
Net worth history
Annual ranking
Net worth over time
Real-time ranking
Financial assets
NASDAQ | MRNA-US
Moderna, Inc.NASDAQ | MRNA-US
Moderna, Inc.NASDAQ | MRNA-US
Moderna, Inc.NASDAQ | MRNA-US
Moderna, Inc.NASDAQ | MRNA-US
Moderna, Inc.NASDAQ | MRNA-US
Moderna, Inc.NASDAQ | MRNA-US
Moderna, Inc.Images © Forbes.com. All rights reserved.